“The production of high-tech innovative products is becoming hallmark for the best industrial enterprises in the region”, said Yuri Bernadsky, General Director of the Interregional Association of Enterprises' Managers, analyzing the results of the XXII competition “For Successful Business Development in Siberia “.”
“Sibbiopharm” Ltd. (the former Berdsky plant of biological products) is a modern biotechnological enterprise with 50 years of experience in the production of microbiological products. It is a dynamically developing, knowledge-based biotechnology company that carries out large-scale production of biological products.
At the present time “Sibbiopharm” Ltd. is equipped with modernized production equipment and has modern laboratories, and unique pilot plant for scaling biotechnological processes. Sibbiopharm’s products are used in plant growing, livestock breeding, feed production, alcohol production, brewing and textile industries, environmental protection, healthcare and other industries.
To date, more than 1000 consumers use the products of “Sibbiopharm” Ltd. Not only in Russia, where “Sibbiopharm” is an undoubted leader, but also abroad: in the CIS countries, the European Union, the states of South and South-East Asia, South America, the Middle East.
The enterprise has seriously changed, and a lot had to be created anew, says the veteran of the chemical plant, General Manager of “Sibbiopharm” Michael Efimov. “This includes the structure of production, technological infrastructure, and, of course, the range of products, which we produce. For example, today, as an industrial partner, we are conducting serious joint research in the field of genetics. It is planned to produce three enzymes, which have not been produced in Russia yet. This is really an innovative development. We pay great attention to treatment process. The quality of this work is a key condition for the competitiveness of a modern biotechnological enterprise. That is why “Sibbiopharm” is “number one” in Russia. It is a company, which strives to meet the best world biotechnology standards.”
According to the company's technical director Lyubov Zakharova, “Sibbiopharm” Ltd. strives to create industrial biotechnology that is competitive on a national and global scale. The solution of this ambitious aim is unthinkable without partnership with the scientific community. “Sibbiopharm” Ltd. closely cooperates with leading Russian and foreign research centers, develops and implements joint promising developments. Today, the total volume of commodity production of the enterprise, depending on the nomenclature, ranges from 8 to 15 thousand tons of commercial output per year.
№ 25(1110), 27.06.2018 г. Sergey GONTARENKO,
« CHESTNOYE SLOVO »
“Sibbiopharm” Ltd. (the former Berdsky plant of biological products) is a modern biotechnological enterprise with 50 years of experience in the production of microbiological products. It is a dynamically developing, knowledge-based biotechnology company that carries out large-scale production of biological products.
At the present time “Sibbiopharm” Ltd. is equipped with modernized production equipment and has modern laboratories, and unique pilot plant for scaling biotechnological processes. Sibbiopharm’s products are used in plant growing, livestock breeding, feed production, alcohol production, brewing and textile industries, environmental protection, healthcare and other industries.
To date, more than 1000 consumers use the products of “Sibbiopharm” Ltd. Not only in Russia, where “Sibbiopharm” is an undoubted leader, but also abroad: in the CIS countries, the European Union, the states of South and South-East Asia, South America, the Middle East.
The enterprise has seriously changed, and a lot had to be created anew, says the veteran of the chemical plant, General Manager of “Sibbiopharm” Michael Efimov. “This includes the structure of production, technological infrastructure, and, of course, the range of products, which we produce. For example, today, as an industrial partner, we are conducting serious joint research in the field of genetics. It is planned to produce three enzymes, which have not been produced in Russia yet. This is really an innovative development. We pay great attention to treatment process. The quality of this work is a key condition for the competitiveness of a modern biotechnological enterprise. That is why “Sibbiopharm” is “number one” in Russia. It is a company, which strives to meet the best world biotechnology standards.”
According to the company's technical director Lyubov Zakharova, “Sibbiopharm” Ltd. strives to create industrial biotechnology that is competitive on a national and global scale. The solution of this ambitious aim is unthinkable without partnership with the scientific community. “Sibbiopharm” Ltd. closely cooperates with leading Russian and foreign research centers, develops and implements joint promising developments. Today, the total volume of commodity production of the enterprise, depending on the nomenclature, ranges from 8 to 15 thousand tons of commercial output per year.
№ 25(1110), 27.06.2018 г. Sergey GONTARENKO,
« CHESTNOYE SLOVO »